Overseas Clinical Trials Criticized

An article published Thursday in The New England Journal of Medicine about drug companies' globalization of clinical trials, the human studies that determine the safety and efficacy of medicines, "raises questions about the ethics and the science of increasingly conducting studies outside the United States — when the studies are meant to gather evidence for new drugs to gain approval in this country." Read more.